Plant-derived nanomaterials (PDNM) have gained significant attention recently due to their potential pharmacological applications against metabolic diseases. Plant-derived natural compounds are significant resources for the discovery of potential anticancer drugs due to their unique properties, including their small size, high surface area, and ability to penetrate biological barriers. While research in the plant-based anticancer field has surged in recent years, systematic bibliometric analyses covering a longer period and containing up-to-date publications remain scarce. In this study, efforts are being made to measure plant nanomaterial research, especially as cancer treatment output published in the form of scholarly literature. The data, for the period of 2020-2026, were extracted from the Scopus abstract and citation database and analyzed by using bibliometric techniques. Our findings showed that the number of plant anticancer-related publications underwent an accelerating growth from 2020-2026. The primary publications were domains of biochemistry genetics and molecular biology, pharmacology, toxicology and pharmaceutics, medicine, and chemistry. Additionally, we noted that plants as natural resources have a big potential as cancer therapy and these innovative plant-based nonsystems may be a promising contender for various pharmacological applications. Our study provides new insights into the progress and trends in the plant anticancer field and will assist researchers in grasping the future research direction.
Herliniati et al. (Thu,) studied this question.